BNP Paribas Financial Markets’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

BNP Paribas Financial Markets’s Portfolio CYTH Stock Details CYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1	Closed	-$1	–	5625
2024 Q4	$1	Buy	+1	New	+$1	﹤0.01%	5394

BNP Paribas Financial Markets's CYTH Position: Q1 2025 in Review

BNP Paribas Financial Markets sold out of Cyclo Therapeutics, Inc. Common Stock (CYTH) in Q1 2025, closing a stake of 1 share — an estimated $1 sold.

BNP Paribas Financial Markets first reported a position in CYTH in Q4 2024 and held it in 1 quarter. The position peaked at $1 in Q4 2024. 0 funds tracked by Wall St. Rank hold CYTH as of Q1 2025.

BNP Paribas Financial Markets reported no remaining Cyclo Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
BNP Paribas Financial Markets sold 1 Cyclo Therapeutics, Inc. Common Stock share in Q1 2025, an estimated $1.
BNP Paribas Financial Markets first reported a position in Cyclo Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
BNP Paribas Financial Markets's Cyclo Therapeutics, Inc. Common Stock position peaked at $1 in Q4 2024.
0 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Common Stock as of Q1 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.